Bosh sahifa000100 ā¢ KRX
add
Yuhan Corp
Yopilish kursi
127Ā 900,00Ā ā©
Kunlik diapazon
127Ā 900,00Ā ā© - 132Ā 300,00Ā ā©
Yillik diapazon
57Ā 500,00Ā ā© - 166Ā 900,00Ā ā©
Bozor kapitalizatsiyasi
10,56Ā trln KRW
OŹ»rtacha hajm
1,53Ā mln
Narx/foyda
59,45
Dividend daromadliligi
-
Bozor yangiliklari
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (KRW) | sen, 2024info | Y/Y qiyosi |
|---|---|---|
Daromad | 598,78Ā mlrd | 23,96% |
Joriy xarajat | 192,76Ā mlrd | 34,67% |
Sof foyda | 37,43Ā mlrd | 91,05% |
Sof foyda marjasi | 6,25 | 53,94% |
Har bir ulushga tushum | 499,00 | 84,49% |
EBITDA | 62,99Ā mlrd | 427,83% |
Amaldagi soliq stavkasi | 28,60% | ā |
Balans
Jami aktivlari
Jami passivlari
| (KRW) | sen, 2024info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 249,00Ā mlrd | -16,62% |
Jami aktivlari | 2,93Ā trln | 9,68% |
Jami passivlari | 751,18Ā mlrd | 18,20% |
Umumiy kapital | 2,17Ā trln | ā |
Tarqatilgan aksiyalar | 75,00Ā mln | ā |
Narxi/balansdagi bahosi | 4,53 | ā |
Aktivlardan daromad | 4,09% | ā |
Kapitaldan daromad | 4,94% | ā |
Pul aylanmasi
Naqd pulning sof oŹ»zgarishi
| (KRW) | sen, 2024info | Y/Y qiyosi |
|---|---|---|
Sof foyda | 37,43Ā mlrd | 91,05% |
Operatsiyalardan naqd pul | -11,81Ā mlrd | -140,91% |
Sarmoyadan naqd pul | -50,05Ā mlrd | 15,74% |
Moliyadan naqd pul | 13,60Ā mlrd | -71,76% |
Naqd pulning sof oŹ»zgarishi | -49,20Ā mlrd | -339,91% |
BoŹ»sh pul | -83,06Ā mlrd | -75,76% |
Haqida
Yuhan Corporation is a South Korean pharmaceutical and chemical company headquartered in Daebang-dong, Dongjak-gu, Seoul. It was established in 1926 by New Il-han and has been listed on the Korea Stock Exchange since 1962. Yuhan is one of the top Korean pharmaceutical companies, along with Celltrion, Samsung Biologics, GC Pharma, and Hanmi Pharmaceutical. Wikipedia
CEO
Tashkil etilgan
1926
Sayt
Xodimlar soni
1Ā 994
